Form 8-K GLOBUS MEDICAL INC For: Feb 20
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- S&P, Dow edge higher on Mideast deal hopes; SpaceX debut in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil falls to near two-month lows as Trump calls off threatened strikes on Iran
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Wall St set to gain on tech rebound, Middle East in focus
Truist Securities Reiterates Hold Rating on Globus Medical (GMED)
February 24, 2025 2:46 PM ESTTruist Securities analyst Richard Newitter reiterated a Hold rating and $90.00 price target on Globus Medical (NYSE: GMED)
The analyst comments "GMED's relatively broad/clean 4Q beat was somewhat clouded by ongoing q's re: the unexpected NVRO deal (announced 2/6 [HERE]). We think... More
